Newsletter | February 17, 2026

02.17.26 -- Digital Protocols Are At An Inflection Point

SPONSOR

Join Clinical Leader Live Chief Editor Dan Schell on February 18, at 1pm Eastern, for this anticipated discussion on AI that will go beyond the buzzwords to focus on what’s actually working in clinical operations. You will hear about some of the newest real-world applications, lessons learned from early adopters, and how to spot hype before it costs you time or money. Register for free thanks to support from our sponsors.

CLINICAL TRIAL TECHNOLOGY

Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders

Digital protocols could reduce manual effort and enable rapid and more consistent downstream study execution, reporting, and submission processes. TransCelereate BioPharma's Rob DiCicco and Novartis' Bill Illis explain.

Ensuring Timeliness, Completeness, And Quality With Digital Solutions

A well-maintained TMF, supported by digital solutions, is the backbone of successful clinical trials, improving trial management and readiness for audits or regulatory submissions.

Improving The eCOA Experience

Discover how template-driven builds and reuse can slash eCOA timelines by 50% while solving the licensing and translation hurdles that delay First Patient In.

Hospital-Based eCOA Implementation

This resource outlines the challenges in infectious disease trials and proven strategies to reduce delays, improve compliance, and meet regulatory standards for PRO data in infectious disease studies.

Digital Biomarkers Solution May Enable Smaller, Faster Clinical Trials

See how sponsors of Huntington’s disease (HD) clinical trials can potentially obtain earlier indications of progress by utilizing digital biomarkers.

IQVIA eCOA Scribe Application

Experience seamless, secure, and flexible eCOA data collection with our application designed for diverse users and equipped with offline functionality and robust authentication.

eCOA: Participant-Focused And Built For Global Trials

High-quality outcome data is essential to clinical trial success, and this eCOA solution provides participant-first design features while supporting multiple modalities.

SPONSOR

Electronic consent (eConsent) systems have proven to add value to patients, sponsors, and sites. However, varying regulations across regions and countries can impact implementation of eConsent solutions and dilute the benefits. Join us and delve into global regulatory scenarios and options for meeting eSignature requirements and learn what to look for in eConsent solutions to ensure you’re prepared for every trial. Learn more

CHOOSE YOUR OWN ADVENTURE

You're receiving the Tuesday edition of the Clinical Leader newsletter, focusing on Clinical Trial Technology. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: